enGene Therapeutics Inc. (ENGN) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$99.24M | -105.5% |
| 2024 | -$48.28M | -95.1% |
| 2023 | -$24.74M | -40.6% |
| 2022 | -$17.59M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$99.24M | -105.5% |
| 2024 | -$48.28M | -95.1% |
| 2023 | -$24.74M | -40.6% |
| 2022 | -$17.59M | — |